"Neurodegenerative disorders are a collection of diseases for which there are very few effective treatments and many risk factors," said co-author Andrew Singleton, a neurogeneticist and Alzheimer's researcher and the director of the Center for Alzheimer's and Related Dementias.
Date: Jan 29, 2023
Category: Health
Source: Google
Six new genetic risk factors for Parkinson's found
"Unravelling the genetic underpinnings of Parkinson's is vital to understanding the multiple mechanisms involved in this complex disease, and hopefully, may one day lead to effective therapies," said Andrew Singleton, a scientist at the US National Institutes of Health's National Institute on Aging
Date: Jul 28, 2014
Category: Health
Source: Google
New Gene Holds Promise for Understanding Alzheimer's
"This is a very important finding because it gives us another target for the disease," says Andrew Singleton, a neuroscientist at NIA who worked on the study with John Hardy. "The best way to understand the disease is to understand the process and develop therapies from there." 2012 USA TODA
Date: Nov 20, 2012
Category: Health
Source: Google
Alzheimer's risk gene points to role of inflammation
"It's another piece in the puzzle. It suggests the immune system is important in Alzheimer's disease," said Andrew Singleton, a geneticist with the U.S. National Institute on Aging, which helped pay for the study.
Date: Nov 15, 2012
Category: Health
Source: Google
Gene Mutation That Hobbles Immune Response Is Linked to Alzheimer's
Meanwhile, Dr. Hardy and Rita Guerreiro at University College London, along with Andrew Singleton and at the National Institute on Aging, were intrigued by a strange, rare disease. Only a few patients had been identified, but their symptoms were striking. They had crumbling bones and an unusual deme